- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05378581
Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children (REVAPRICK)
Evaluation of the Use of a Virtual Reality Mask During Blood Tests and Prick Tests Performed in Allergic Children Aged 7 to 13 Years: a Multicenter, Randomized Trial
Main objective :
Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years.
Hypothesis :
Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxiety and pain
Study Overview
Status
Intervention / Treatment
Detailed Description
Investigation of food or respiratory allergy is based on prick tests and serum specific immunoglobulin E assays. The nurse often controls the blood test pain but during the skin tests, many children cry, feeling both fear and pain. This traumatic experience will in most cases be repeated during the child's allergic follow-up.
To date, there are few effective means of limiting anxiety and pain associated with prick tests and therefore little research work on this subject.
Immersion in virtual reality (VR) seems to be an interesting way of distraction for children from 7 to 13 years needing this treatment. Indeed, it makes it possible to saturate the sensorially of the child thus reducing the nociceptive perceptions and the anxiety. The choice of VR mask with pediatric program specific seems interesting for this children This is a randomized, open-label, two-armed parallel, multicenter therapeutic trial comparing an analgesic strategy using authorized medical devices (conventional strategy) with a virtual reality mask distraction technique for allergics tests in children from 7 to 13 years old hospitalized in the pediatric consultation of Clermont Ferrand University Hospital and in the day hospital of Saint-Etienne University Hospital
The control arm is the local anesthetic cream (for the blood test) arm with distraction from nurse/parents +/-anesthesic and anxiolytic gas and the experimental arm is the local anesthetic cream + virtual reality mask distraction
The nurse informs and obtains the consent of the child and his parents. Then she measures child's pain and anxiety before the care, during the blood test, at the third prick test and immediately after the care.
She also notes the anxiety of the parents before and after the care. Finally, the satisfaction of the child, parents, nurses will be collected at the end of the care.
After statistical analysis of these two arms, it will be possible to determine the value of the virtual reality mask to reduce the child's pain and anxiety during the pricks tests.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63000
- CHU de Clermont-Ferrand
-
Saint-Étienne, France, 42000
- CHU de Saint Etienne
-
Principal Investigator:
- Christine REDURON
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children from 7 to 13 years old requiring blood test and prick tests in pediatric consultation at the Clermont-Ferrand University Hospital and in the pediatric's day hospital at the Saint-Etienne University Hospital
- Subjects and their parents who were informed about the study and gave informed consent
- Enrollment in the Social Security system
- Children and parents able to use the self-report scales proposed in the study
Exclusion Criteria:
Children from 7 to 13 :
- presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post-traumatic stress disorder)
- Having a modification of pain's integration (spina bifida for example)
- Having received an analgesic before the care
- Requiring contact isolation
- With a history of seizures or motion sickness
- Refusal of the parents and/or the child
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: standard
Use local anesthesic cream + nurse or parents distraction +/- anesthesic or anxiolytic gas
|
usual process
|
EXPERIMENTAL: virtual reality
Use local anesthesic cream and virtual reality mask
|
virtual reality mask Deepsen® with age-appropriate software Birdy®
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
children's pain hetero-evaluation
Time Frame: during blood test
|
children's pain evaluation by the nurse with the visual analog scale quote from 0 to 10, 10=worst score
|
during blood test
|
children's pain hetero-evaluation
Time Frame: during procedure (prick test)
|
children's pain evaluation by the nurse with the visual analog scale from 0 to 10, 10= worst score
|
during procedure (prick test)
|
children's pain self-evaluation
Time Frame: 5 min after the care
|
self evaluation of children's pain with the visial analog scale in vertical position quote from 0 to 10, 10=worst score
|
5 min after the care
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change from baseline children's anxiety at just after the care
Time Frame: before the care and 5 min after the care
|
self-evaluation of children's anxiety with the scale "child fear scale" quote from 0 to 4, 4= worst score
|
before the care and 5 min after the care
|
children's anxiety hetero evaluation
Time Frame: during blood test
|
children's anxiety evaluation by the nurse with the scale "child fear scale" quote from 0 to 4, 4= worst score
|
during blood test
|
children's anxiety hetero evaluation
Time Frame: during procedure (prick tests)
|
children's anxiety evaluation by the nurse with the scale "child fear scale" quote from 0 to 4, 4= worst score
|
during procedure (prick tests)
|
change from baseline parents' anxiety at just after the care
Time Frame: before the care and 5 min after the care
|
self-evaluation of parents' anxiety with the numerical scale quote from 1 to 10, 10= worst score
|
before the care and 5 min after the care
|
evaluation of the care
Time Frame: 5 min after the care
|
satisfaction of the care for children, parents and nurses with satisfaction questionnaire for children : a score from 1 to 3 (3=best score, very satisfied) for parents with a score from 1 to 5 (5= best score, very satisfied) and for nurse with a score from 1 to 5 (5= best score, very satisfied)
|
5 min after the care
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GIRCI 2020 USCLADE
- 2021-A02125-36 (OTHER: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Testicular Diseases
-
Haukeland University HospitalKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingSeminoma | Testicular Germ Cell Cancer | Non-Seminoma Testicular Cancer | Stage I Testicular Cancer | Stage II Testicular Cancer | Stage III Testicular Cancer | Stage IV Testicular Cancer | Relapse Testicular CancerNorway, Sweden
-
University Medical Center GroningenDutch Cancer SocietyCompletedNon-seminomatous Testicular CancerNetherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Seminoma | Testicular Yolk Sac Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular Germ Cell Tumor | Ovarian Embryonal Carcinoma | Ovarian Yolk Sac Tumor | Testicular Embryonal Carcinoma | Ovarian Choriocarcinoma | Ovarian Mixed Germ Cell Tumor | Testicular Choriocarcinoma and other conditionsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingSeminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8Canada, United States, Guam
-
Erasmus Medical CenterRecruitingQuality of Life | Testicular Germ Cell Tumor | Testicular CancerNetherlands
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingLymphadenopathy | Stage I Testicular Seminoma | Stage II Testicular SeminomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedTesticular Yolk Sac Tumor | Recurrent Ovarian Germ Cell Tumor | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Malignant Testicular Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Malignant Ovarian Germ Cell Tumor | Childhood Malignant Testicular Germ Cell Tumor | Ovarian... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
University Medical Center GroningenDutch Cancer SocietyRecruitingTesticular CancerNetherlands
-
Radboud University Medical CenterCompletedTesticular CancerNetherlands
-
Centre Hospitalier Universitaire de NiceTerminatedTesticular CancerFrance
Clinical Trials on control arm
-
Centre Leon BerardNational Cancer Institute, France; Fondation de France; Cancéropôle Lyon Auvergne... and other collaboratorsCompletedImpact of Nutritional Intervention in Women With Breast Cancer Under Adjuvant Chemotherapy (PASAPAS)Breast Cancer | Adequate Physical ConditionFrance
-
Imperial College LondonKing Khalid UniversityRecruitingCardiovascular Diseases | Acute Coronary SyndromeUnited Kingdom
-
Kaiser PermanenteRecruitingAdolescent Behavior | Mental Health IssueUnited States
-
Heart of England NHS TrustAstraZenecaUnknown
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); St. Justine's HospitalActive, not recruitingDiabetes Mellitus, Type 1 | Type1diabetes | Insulin Dependent DiabetesCanada
-
Lawson Health Research InstituteCompletedChronic Kidney DiseaseCanada
-
Herlev and Gentofte HospitalUniversity of Aarhus; Danish Cancer Society; The Novo Nordic Foundation; University...Recruiting
-
Kaiser Clinic and HospitalCompletedObesity | Weight GainBrazil
-
Duke UniversityTerumo BCTCompletedAllogenic Transfusion of Platelets During Cardiac SurgeryUnited States
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruitingStroke | Aging Problems | Innovative Rehabilitation Treatment Based on RoboticsItaly